Two Sigma Investments, LP Synlogic, Inc. Transaction History

Two Sigma Investments, LP

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 15, 2023	SELL	$0.56 - $1.07 $4,256 - $8,132	-7,600 Reduced 9.27%	74,352 $46,000
Q4 2022 Feb 14, 2023	SELL	$0.58 - $17.99 $6,988 - $216,779	-12,050 Reduced 12.82%	81,952 $62,000
Q3 2022 Nov 14, 2022	SELL	$0.91 - $14.63 $3,012 - $48,425	-3,310 Reduced 3.4%	94,002 $89,000
Q2 2022 Aug 15, 2022	SELL	$0.89 - $2.47 $29,144 - $80,885	-32,747 Reduced 25.18%	97,312 $112,000
Q1 2022 May 16, 2022	SELL	$1.63 - $2.55 $352,158 - $550,922	-216,048 Reduced 62.42%	130,059 $312,000
Q4 2021 Feb 14, 2022	SELL	$2.27 - $3.0 $230,502 - $304,629	-101,543 Reduced 22.68%	346,107 $838,000
Q3 2021 Nov 15, 2021	SELL	$2.45 - $4.1 $538,811 - $901,684	-219,923 Reduced 32.94%	447,650 $1.37 Million
Q2 2021 Aug 16, 2021	BUY	$3.0 - $4.39 $500,793 - $732,827	166,931 Added 33.34%	667,573 $2.6 Million
Q1 2021 May 17, 2021	BUY	$2.2 - $5.05 $225,013 - $516,508	102,279 Added 25.67%	500,642 $1.79 Million
Q4 2020 Feb 16, 2021	BUY	$1.85 - $2.54 $203,886 - $279,930	110,209 Added 38.25%	398,363 $860,000
Q3 2020 Nov 16, 2020	SELL	$1.85 - $2.57 $109,238 - $151,753	-59,048 Reduced 17.01%	288,154 $582,000
Q2 2020 Aug 14, 2020	SELL	$1.59 - $2.51 $40,727 - $64,293	-25,615 Reduced 6.87%	347,202 $705,000
Q1 2020 May 15, 2020	SELL	$1.39 - $3.19 $25,977 - $59,617	-18,689 Reduced 4.77%	372,817 $641,000
Q4 2019 Feb 14, 2020	BUY	$1.96 - $2.81 $647,915 - $928,898	330,569 Added 542.48%	391,506 $1.01 Million
Q3 2019 Nov 14, 2019	BUY	$2.12 - $9.37 $129,186 - $570,979	60,937 New	60,937 $140,000

25.5K

Ticker SYBX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 70,229,600
Market Cap $103M
Description
Synlogic, Inc., a clinical-stage biopharmaceutical company, engages in the discovery and development of synthetic biotic medicines to treat metabolic and immunological diseases in the United States. Its therapeutic programs include SYNB1618 and SYNB1934 that are orally administered, non-systemically absorbed drug candidates, which are in Phase I...

Get notified when there are updates to the investment portfolio of Two Sigma Investments, LP, based on Form 13F filings with the SEC.

Stay updated on Two Sigma Investments, LP with notifications on news.